Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interaction of molecular alterations with immune response in melanoma.

Cancer - 1 Jun 2017

Szczepaniak Sloane Robert A, Gopalakrishnan Vancheswaran, Reddy Sangeetha M, Zhang Xue, Reuben Alexandre, Wargo Jennifer A

Abstract excerpt

Major advances have been made in melanoma treatment with the use of molecularly targeted therapies and immunotherapies, and numerous regimens are now approved by the US Food and Drug Administration for patients with stage IV disease. However, therapeutic resistance remains an issue to both classes of agents, and reliable biomarkers of therapeutic response and resistance are lacking. Mechanistic insights are being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ipilimumab
Share to MAP Kinase Kinase 1
Share to Nivolumab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oximes

Share to Pyridones

Share to Pyrimidinones

Share to Tumor Escape

Share to Vemurafenib

Source

Open in PubMed Open full text

Identifiers

PMID: 28543700
DOI: 10.1002/cncr.30681
PMCID: PMC6105277

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interaction of molecular alterations with immune response in melanoma.PMID 28543700Read ↗

Molecular, Genetic Susceptibility and Immunotherapy of MelanomaSemantic proximity Read ↗

Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanomaSemantic proximity Read ↗

Molecular Susceptibility and Treatment Challenges in Melanoma.Semantic proximity Read ↗

Signaling and Immune Regulation in Melanoma Development and Responses to TherapySemantic proximity Read ↗

Understanding the biology of melanoma and therapeutic implications.Semantic proximity Read ↗

Pathways and therapeutic targets in melanoma.Semantic proximity Read ↗

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An UpdateSemantic proximity Read ↗

Advances in Melanoma: From Genetic Insights to Therapeutic InnovationsSemantic proximity Read ↗

Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.Semantic proximity Read ↗

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read ↗

Evolution of Molecular Targets in Melanoma Treatment.Semantic proximity Read ↗

Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.